Literature DB >> 758493

Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine.

V V Kakkar, J D Stamatakis, P G Bentley, D Lawrence, H A de Haas, V P Ward.   

Abstract

Randomized clinical trials in 300 patients undergoing major abdominal surgery or hip replacement arthroplasty were performed to investigate the efficacy of dihydroergotamine mesylate, heparin calcium, or a combination of dihydroergotamine with heparin in preventing postoperative deep-vein thrombosis (DVT). The diagnosis of DVT was established by an uptake test using fibrinogen labeled with iodine 125; in patients undergoing hip replacement, phlebography was also employed to confirm or refute the presence of isotopic thrombi. The data indicate that the combination of dihydroergotamine and heparin is more effective than heparin or dihydroergotamine alone in preventing DVT.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 758493

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  21 in total

1.  [Perioperative prevention of thromboembolism in gynecology].

Authors:  W E Schreiner
Journal:  Arch Gynecol       Date:  1986

Review 2.  Venous thromboembolism: epidemiology, diagnosis, prevention.

Authors:  D M Becker
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

3.  [Prevention of thromboembolism in surgery--obligatory today?].

Authors:  H J Streicher; J Kussmann; K Koppenhagen; R Häring; W Theiss; J Adolf; S Haas; H Reilmann; H Tscherne; J R Siewert
Journal:  Langenbecks Arch Chir       Date:  1988

Review 4.  Anticoagulants in anaesthesia.

Authors:  P J Stow; F A Burrows
Journal:  Can J Anaesth       Date:  1987-11       Impact factor: 5.063

5.  Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine.

Authors:  M R Lassen; L C Borris; H M Christiansen; F Møller-Larsen; V E Knudsen; P Boris; A M Nehen; A G Jurik; A de Carvalho; B W Nielsen
Journal:  Arch Orthop Trauma Surg       Date:  1989       Impact factor: 3.067

6.  The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force.

Authors:  B T Colvin; T W Barrowcliffe
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

7.  The effect of prophylaxis for thrombosis on heterotopic ossification following total hip joint replacement.

Authors:  R Eyb; K Knahr
Journal:  Arch Orthop Trauma Surg       Date:  1983

8.  Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man.

Authors:  W H Aellig
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.

Authors:  P F Leyvraz; F Bachmann; J Hoek; H R Büller; M Postel; M Samama; M D Vandenbroek
Journal:  BMJ       Date:  1991-09-07

10.  [Prevention of thromboembolism with heparin-DHE--safety and trends].

Authors:  R Häring; K Koppenhagen
Journal:  Langenbecks Arch Chir       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.